Acorah Software Products - Accounts Production 16.8.310 false true 30 September 2024 1 October 2023 false true No description of principal activity 1 October 2024 30 September 2025 30 September 2025 11572654 Mrs Muriel Wallace-Scott iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 11572654 2024-09-30 11572654 2025-09-30 11572654 2024-10-01 2025-09-30 11572654 frs-core:CurrentFinancialInstruments 2025-09-30 11572654 frs-bus:PrivateLimitedCompanyLtd 2024-10-01 2025-09-30 11572654 frs-bus:FilletedAccounts 2024-10-01 2025-09-30 11572654 frs-bus:Micro-entities 2024-10-01 2025-09-30 11572654 frs-bus:AuditExempt-NoAccountantsReport 2024-10-01 2025-09-30 11572654 frs-bus:Director1 2024-10-01 2025-09-30 11572654 2023-09-30 11572654 2024-09-30 11572654 2023-10-01 2024-09-30 11572654 frs-core:CurrentFinancialInstruments 2024-09-30
Registered number: 11572654
Autoimmune Clinic London Ltd
Financial Statements
For The Year Ended 30 September 2025
Balance Sheet
Registered number: 11572654
2025 2024
£ £
Fixed assets 7,396 3,584
Current assets 43,972 45,770
Creditors: Amounts Falling Due Within One Year (39,073 ) (8,401 )
NET CURRENT ASSETS 4,899 37,369
TOTAL ASSETS LESS CURRENT LIABILITIES 12,295 40,953
NET ASSETS 12,295 40,953
CAPITAL AND RESERVES 12,295 40,953

Notes

1. General Information
Autoimmune Clinic London Ltd is a private company, limited by shares, incorporated in England & Wales, registered number 11572654 . The registered office is 4 Florence Road, Walton-on-Thames, Surrey, KT12 2AL.
2. Average Number of Employees
Average number of employees, including directors, during the year was: 1 (2024: 1)
1 1
For the year ending 30 September 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The member has not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges her responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
On behalf of the board
Mrs Muriel Wallace-Scott
Director
15 January 2026